Another potential therapeutic agent, an alkaloid, lycorine, seems to prevent BLM-induced PF by inactivating NLRP3 inflammasome and pyroptosis PYD domain of ASC (167). The gene discussed is NLRP3; the disease is pemphigus foliaceus.